Registration is required for this free webinar
Hosted by the SOT Stem Cells Specialty Section
New approach methodologies (NAMs) provide alternative testing strategies to reduce or replace animals used for testing chemical safety, drug toxicity, and adverse health outcomes. In recent years, organoid models have emerged as a promising tool for NAMs. Organoids are three-dimensional cell cultures derived from human stem cells and primary tissue cells, and they provide an alternative model that reflects the original tissue's composition, architecture, and function. In many cases, they recapitulate specific tissue responses to a toxicant. Despite this promise, there are few examples of successful implementation of organoid models in the context of NAMs for the toxicological community. This session will bring together experts to discuss the potential of organoid-based NAMs for advancing toxicological testing. Dr. Srivatsan Kidambi will speak about standardization of organoid models for toxicity testing, regulatory science, and clinical translation. Dr. Julie G. In will discuss intestinal organoids as a model system to study host-toxicant interactions.
Speakers
Srivatsan Kidambi, PhD, Director, NIH Standardized Organoid Modeling (SOM) Center
Julie G. In, PhD, Associate Professor, Department of Internal Medicine (GI Division), University of New Mexico Health Sciences Center